Previous 10 | Next 10 |
home / stock / sdmhf / sdmhf news
2023-10-20 17:03:02 ET Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Conference Call October 20, 2023, 6:30 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financial Officer Rene Faber - Chief Executive Offic...
2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...
2023-09-19 10:00:00 ET Summary I am a 24-year-old investor aiming for financial freedom through long-term investing in companies with good management and growth potential. I made changes to the portfolio, buying stocks such as UFP Industries and Ulta Beauty, and selling stocks lik...
2023-07-21 17:47:09 ET Sartorius Stedim Biotech S.A. (SDMHF) Q2 2023 Earnings Conference Call July 21, 2023 09:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO René Fáber - Head, Bioprocess Solutions and CEO, Sartorius Stedim B...
2023-07-21 14:35:23 ET Sartorius Stedim Biotech S.A. press release ( OTCPK:SDMHF ): 1H GAAP EPS of €2.62. Revenue of €1.41B (-18.0% Y/Y). For further details see: Sartorius Stedim Biotech S.A. GAAP EPS of €2.62, revenue of €1.41B
2023-07-19 13:50:00 ET Summary Mawer Investment Management is a privately owned, independent investment firm, managing over $67B in assets for individual and institutional investors across all major asset classes. Globally, equity markets continued to be resilient in the second qu...
2023-07-01 03:47:27 ET Summary Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector. We will review all the negative factors that are curren...
2023-06-26 11:00:28 ET Summary The bioprocessing market is currently in a downturn and pulling companies like Danaher and Sartorius down. Danaher has a clean balance sheet to make good deals in this downturn. Margins have temporary headwinds but should recover in 2024. At ...
2023-06-20 05:46:45 ET Summary Sartorius AG's stock price fell over 15% after the company lowered its forecast significantly. Sartorius may also fail to achieve its 2025 revenue targets, despite reaffirming its guidance in that regard. The €2.4 billion acquisition of Po...
2023-04-03 13:00:00 ET Summary Sartorius announced the 2.4 billion euro acquisition of Polyplus. Polyplus is producing transfection reagents and generates <100 million euros in revenues. The acquisition appears to be very expensive and management has not explained the reaso...
News, Short Squeeze, Breakout and More Instantly...
Sartorius Stedim Biotech Company Name:
SDMHF Stock Symbol:
OTCMKTS Market:
Nine-month results 2022 of Sartorius Stedim Biotech PR Newswire Sales revenue up 17.0 percent in constant currencies, underlying EBITDA margin at 35.0 percent Overall market situation characterized by innovations and strong growth drivers; current development as ex...
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions PR Newswire UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly innovative and profitable company Re...
Half-year results 2022 of Sartorius Stedim Biotech PR Newswire AUBAGNE, France , July 21, 2022 Sales revenue up 22.1 percent in constant currencies, underlying EBITDA margin 35.2 percent 2022 outlook confirmed: Sales revenue expected...